Dr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma.

Although there is no definitive proof that lavender and tea tree oils act as endocrine disruptors, studies suggest a possible link.

Dr Weber discusses two studies that show a clear survival advantage with ipilimumab, but at a significant price in toxicity.

In a preview of ASCO melanoma studies, the NEMO results suggest that binimetinib is reasonable for NRAS-mutated melanoma, and combo regimens continue to show strong outcomes, reports Dr Jeffrey Weber.

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.

Zubin Damania, an internist and rapper/singer who performs musical parodies under the name ZDoggMD, talks with Eric Topol about his love for Weird Al and his novel medical practice, Turntable Health.

In Part 1 of Critical Issues in Dermatology, Drs Charles Vega and Graeme Lipper discuss some common dermatologic conditions and how to best manage them.

Eric Topol speaks with author Siddhartha Mukherjee about his latest book, The Laws of Medicine, and how uncertainty, imperfections, priors, outliers, and biases affect these laws.

When the Antibiotic Resistance National Action Plan was announced, our readers had many concerns and questions. We asked CDC Director Tom Frieden for answers.

Paul G. Auwaerter, MD, reviews treatment choices, recent research, and his 'bottom line' for treating skin and soft tissue infections.